Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device

被引：40
|
作者：
Zietkiewicz, M [1 ]
Garlicki, M [1 ]
Domagala, J [1 ]
Wierzbicki, K [1 ]
Drwila, R [1 ]
Pfitzner, R [1 ]
Dziatkowiak, A [1 ]
机构：
[1] Jagiellonian Univ, Collegium Medicum, Inst Cardiol, Dept Cardiovasc Surg & Transplantat, Krakow, Poland
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2002年 / 123卷 / 02期
关键词：
D O I：
10.1067/mtc.2002.119328
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [1] Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device
    Potapov, EV
    Pasic, M
    Bauer, M
    Hetzer, R
    ANNALS OF THORACIC SURGERY, 2002, 74 (06): : 2182 - 2183
  • [2] Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation
    Kogan, A
    Berman, M
    Kassif, Y
    Raanani, E
    Stamler, A
    Ben Gal, T
    Stein, M
    Erez, E
    Vidne, BA
    Sahar, G
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (03): : 347 - 349
  • [3] Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII
    Flynn, JD
    Camp, PC
    Jahania, MS
    Ramaiah, C
    Akers, WS
    ASAIO JOURNAL, 2004, 50 (05) : 519 - 521
  • [4] Use of activated recombinant factor VII (rVIIa) for severe coagulopathy post ventricular assist device (VAD)
    Gandhi, M. J.
    Pierce, R. A.
    Zhang, L.
    Moon, M. R.
    Despotis, G. M.
    Moazami, N.
    TRANSFUSION, 2006, 46 (09) : 156A - 156A
  • [5] High Incidence of Thromboembolic Events in Left Ventricular Assist Device Patients Treated With Recombinant Activated Factor VII
    Bruckner, Brian A.
    DiBardino, Daniel J.
    Ning, Qian
    Adeboygeun, Alfred
    Mahmoud, Karim
    Valdes, Jamie
    Eze, John
    Allison, Paul M.
    Cooley, Denton A.
    Gregoric, Igor D.
    Frazier, Oscar H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (08): : 785 - 790
  • [6] Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant
    Gandhi, Manish J.
    Pierce, Richard A.
    Zhang, Lini
    Moon, Marc R.
    Despotis, George J.
    Moazami, Nader
    JOURNAL OF CARDIOTHORACIC SURGERY, 2007, 2 (1)
  • [7] Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant
    Manish J Gandhi
    Richard A Pierce
    Lini Zhang
    Marc R Moon
    George J Despotis
    Nader Moazami
    Journal of Cardiothoracic Surgery, 2
  • [8] Successful treatment of a patient with a severely bleeding peptic ulcer with recombinant activated factor VII
    Vlot, AJ
    Ton, E
    Mackaay, AJC
    Kramer, MHH
    Gaillard, CAJM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 96 - 96
  • [9] Successful treatment of massive bleeding in an obstetric patient using recombinant activated factor VII
    Rivas-Valenzuela, E
    Rangel, EF
    Perez-Rada, FJ
    Saucedo, P
    Sanchez-Nava, VM
    Cedillo-Juarez, J
    Perez-Cornejo, S
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A182 - A182
  • [10] Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec®)
    Fritsch, N.
    Pouquet, O.
    Roux, B.
    Abdelmoumen, Y.
    Janvier, G.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2010, 29 (01): : 45 - 47
12345